Chau-Ting Yeh Selected Research

N-formylmethionylphenylalanine (FMP)

12/2014	Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case-control study.
3/2014	A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma.
7/2011	GALNT14 SNP as a potential predictor of response to combination chemotherapy using 5-FU, mitoxantrone and cisplatin in advanced HCC.
3/2011	Retrospective comparison between a regular and a split-dose protocol of 5-fluorouracil, cisplatin, and mitoxantrone for the treatment of far advanced hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chau-Ting Yeh Research Topics

Disease

88	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 06/2002
79	Neoplasms (Cancer) 09/2022 - 09/2006
32	Chronic Hepatitis B 05/2022 - 01/2002
28	Infections 05/2022 - 06/2002
24	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2008
23	Fibrosis (Cirrhosis) 05/2022 - 06/2002
17	Liver Neoplasms (Liver Cancer) 05/2022 - 06/2011
17	Hepatitis B 05/2022 - 04/2004
17	Hepatitis 01/2019 - 06/2002
9	Hepatitis C 09/2021 - 05/2006
8	Chronic Hepatitis C 04/2021 - 09/2008
8	Inflammation (Inflammations) 05/2018 - 11/2003
7	Carcinogenesis 03/2020 - 08/2009
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 05/2006
5	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 04/2016
3	Chronic Hepatitis (Chronic Active Hepatitis) 01/2022 - 01/2010
3	Disease Progression 09/2017 - 03/2007
2	Non-alcoholic Fatty Liver Disease 05/2022 - 02/2015
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2020
2	Virus Diseases (Viral Diseases) 04/2021 - 02/2018
2	Polyps 09/2020 - 09/2019
2	Prostatic Neoplasms (Prostate Cancer) 11/2019 - 02/2017
2	Fatty Liver 06/2018 - 08/2009
2	Hepatitis E 02/2018 - 01/2017
2	Starvation 01/2018 - 01/2016
2	Viremia 12/2016 - 01/2002
2	Hepatitis D 04/2015 - 05/2012

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2005
17	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2003
17	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 10/2003
16	Thyroid HormonesIBA 05/2022 - 03/2008
15	Antiviral Agents (Antivirals)IBA 01/2022 - 10/2003
11	Long Noncoding RNAIBA 01/2021 - 09/2015
10	MicroRNAs (MicroRNA)IBA 10/2021 - 01/2012
10	Lamivudine (Epivir)FDA Link 12/2020 - 11/2003
9	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 09/2008
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2007
8	Surface Antigens (Surface Antigen)IBA 01/2022 - 02/2007
8	Hepatitis B e AntigensIBA 05/2015 - 01/2002
7	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2006
7	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2021 - 06/2002
6	Telbivudine FDA Link 05/2022 - 09/2013
6	Pharmaceutical PreparationsIBA 05/2022 - 10/2003
6	Alanine Transaminase (SGPT)IBA 01/2021 - 02/2015
6	EnzymesIBA 02/2020 - 05/2012
6	InterferonsIBA 01/2019 - 05/2006
5	Sorafenib (BAY 43-9006)FDA Link 05/2022 - 10/2018
5	entecavir FDA Link 01/2022 - 09/2013
5	Messenger RNA (mRNA)IBA 12/2021 - 02/2009
5	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 10/2019 - 03/2008
4	Nonsense Codon (Nonsense Mutation)IBA 09/2022 - 07/2006
4	Complementary DNA (cDNA)IBA 10/2020 - 08/2003
4	VimentinIBA 01/2020 - 08/2012
4	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 03/2011
4	N-formylmethionylphenylalanine (FMP)IBA 12/2014 - 03/2011
3	AntigensIBA 01/2022 - 10/2015
3	Biological ProductsIBA 01/2022 - 01/2020
3	Fetal Proteins (Fetoprotein)IBA 01/2021 - 07/2014
3	BilirubinIBA 01/2021 - 11/2003
3	Glucose (Dextrose)FDA LinkGeneric 06/2020 - 05/2016
3	AntibodiesIBA 01/2020 - 05/2003
3	Glutamine (L-Glutamine)FDA Link 01/2020 - 01/2016
3	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2020 - 12/2018
3	Protein Isoforms (Isoforms)IBA 10/2019 - 09/2006
3	CytokinesIBA 11/2018 - 04/2016
3	NucleotidesIBA 11/2018 - 01/2010
3	MelatoninIBA 09/2018 - 10/2017
3	Triglycerides (Triacylglycerol)IBA 06/2018 - 02/2015
3	LipidsIBA 05/2018 - 01/2014
3	CholesterolIBA 05/2018 - 02/2015
3	AdipokinesIBA 06/2017 - 07/2012
3	Viral DNAIBA 01/2017 - 09/2006
3	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2014 - 03/2011
3	Fluorouracil (Carac)FDA LinkGeneric 12/2014 - 03/2011
2	AnticoagulantsIBA 05/2022 - 09/2020
2	Adenosine Triphosphate (ATP)IBA 05/2022 - 05/2014
2	Mitochondrial DNA (mtDNA)IBA 01/2022 - 01/2021
2	Tenofovir (Viread)FDA Link 01/2022 - 10/2021
2	Calcibiotic Root Canal SealerIBA 12/2021 - 06/2019
2	Interleukin-17 (Interleukin 17)IBA 04/2021 - 01/2021
2	A-factor (Streptomyces)IBA 10/2020 - 09/2019
2	MucinsIBA 02/2020 - 01/2018
2	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2020 - 01/2018
2	CateninsIBA 01/2020 - 03/2012
2	Etoposide (VP 16)FDA LinkGeneric 09/2018 - 01/2018
2	Transaminases (Aminotransferases)IBA 08/2018 - 07/2005
2	thiamine triphosphorate (TTP)IBA 04/2018 - 07/2014
2	ProteomeIBA 10/2017 - 08/2012
2	Amino Acids FDA Link 02/2017 - 09/2009
2	AlbuminsIBA 01/2017 - 01/2013
2	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 01/2010
2	VaccinesIBA 12/2016 - 06/2010
2	Transcription Factors (Transcription Factor)IBA 09/2016 - 04/2016

Therapy/Procedure

33	Therapeutics 05/2022 - 04/2004
17	Drug Therapy (Chemotherapy) 05/2022 - 10/2003
5	Liver Transplantation 05/2022 - 01/2012
4	Combination Drug Therapy (Combination Chemotherapy) 12/2014 - 03/2011
3	Radiotherapy 03/2020 - 09/2017
3	Hepatectomy 01/2017 - 01/2008
2	Subcutaneous Injections 01/2018 - 07/2008